Passage Bio Inc.

NASDAQ: PASG · Real-Time Price · USD
6.89
-0.70 (-9.22%)
At close: Aug 15, 2025, 3:59 PM
7.10
2.97%
After-hours: Aug 15, 2025, 07:53 PM EDT

Passage Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-56.85M -63.46M -64.77M -68.8M -76.57M -84.44M -102.06M -112.38M -111.97M -127.65M -136.13M -160.21M -180.42M -189.31M -185.39M -173.18M -154.79M -133.53M
Depreciation & Amortization
686K 1.31M 1.92M 2.01M 3.37M 3.55M 3.72M 3.86M 3.83M 3.77M 3.68M 3.4M 2.93M 2.21M 1.54M 1.15M 967K 962K
Stock-Based Compensation
4.43M 5.08M 5.82M 6.14M 7.57M 9.73M 10.92M 12.83M 12.87M 15.4M 18.95M 23.05M 27M 29.29M 32.69M 29.44M 26.66M 21.95M
Other Working Capital
5.95M 6.34M 4.76M -1.48M -6.24M -5.7M 8.13M 10.44M 12.41M 16.73M -3.08M 7.45M 5.27M 2.76M 9.22M 628K 11.35M 12.77M
Other Non-Cash Items
9.47M 9.6M 6.39M 10.57M -2.7M -11.21M -10.87M -15.11M -7.34M 1.3M 3.77M 6.21M 10.61M 12.14M 10.62M 9.74M 3.9M 2.13M
Deferred Income Tax
n/a n/a n/a -4.66M 6.62M 14.68M 14.68M 19.34M 8.06M n/a n/a n/a 889K 1.39M 2.23M 2.82M 1.98M 1.48M
Change in Working Capital
6.2M 4.59M 2.68M -4.29M -9.03M -7.06M 5.34M 8.69M 7.55M 11.23M -8.49M 2.58M -3.64M 3.41M 11.42M 4.5M 19.29M 17.62M
Operating Cash Flow
-36.07M -42.87M -47.96M -59.03M -70.74M -74.75M -78.26M -82.77M -87M -95.94M -118.21M -124.96M -142.63M -140.87M -126.88M -125.53M -102M -89.39M
Capital Expenditures
-34K -34K -34K -33K -17K -120K -146K -607K -2.35M -3.08M -5.27M -12.12M -21.89M -26.57M -25.64M -19.63M -8.26M -2.85M
Cash Acquisitions
1.17M 585K n/a -7.61K -30.07K -44.14K -65.38K 2.94M 2.97M 2.97M 4.49M 9.49M 14.98M 16.5M 15.5M -88.6M -94.1M -95.6M
Purchase of Investments
-37.34M -74.36M -88.17M -100.39M -106.73M -91.84M -129.43M -143.17M -172.49M -171.83M -157.84M -148.99M -129.27M -179.62M -202.55M -300.7M -398.21M -326.38M
Sales Maturities Of Investments
105.07M 143.14M 143.15M 149.29M 163.1M 161.24M 194.81M 198.06M 201.9M 204.01M 188.31M 186.06M 169.31M 198.08M 182.37M 241.57M 203.9M 136.83M
Other Investing Acitivies
n/a n/a n/a 7.61K 30.07K 44.14K 65.38K -2.94M -2.97M -2.97M -4.49M -9.49M -14.98M -16.5M -15.5M 88.6M -41.12M -39.62M
Investing Cash Flow
68.86M 69.33M 54.95M 48.87M 56.35M 69.27M 65.24M 54.28M 27.07M 29.11M 25.2M 24.95M 18.16M -8.11M -45.81M -78.75M -202.57M -192.4M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
111K 97K 97K 50K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.6K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
8.84M 8.87M 8.87M 35K 35K n/a n/a -649K -1.06M -1.46M -1.41M -693K -241K 183K 134K 180K 180K 206K
Financial Cash Flow
61K 132K 8.87M 8.87M 8.87M 8.88M 135K 88.41K 88K -1.4K -1.35K -310 142.00 1.07K 166.66K 568.2K 612.16K -984.37K
Net Cash Flow
32.86M 26.58M 15.86M -1.29M -5.52M 3.4M -12.89M -28.99M -60.84M -68.24M -94.36M -100.32M -124.33M -147.91M -6.04M -37.68M -137.97M -117.31M
Free Cash Flow
-36.1M -42.91M -47.99M -59.06M -70.76M -74.87M -78.41M -83.38M -89.35M -99.02M -123.48M -137.08M -164.51M -167.44M -152.52M -145.16M -110.27M -92.23M